| scholarly article | Q13442814 |
| P2093 | author name string | Valakunja Nagaraja | |
| Sugopa Sengupta | |||
| P2860 | cites work | Recent advances in understanding structure–function relationships in the type II topoisomerase mechanism | Q22121966 |
| Glutamate racemase from Mycobacterium tuberculosis inhibits DNA gyrase by affecting its DNA-binding | Q24674283 | ||
| NMR structure of the Escherichia coli protein YacG: a novel sequence motif in the zinc-finger family of proteins | Q27639582 | ||
| DNA gyrase as a drug target | Q28139769 | ||
| Two-iron rubredoxin of Pseudomonas oleovorans: production, stability and characterization of the individual iron-binding domains by optical, CD and NMR spectroscopies | Q28348005 | ||
| Interaction network containing conserved and essential protein complexes in Escherichia coli | Q29615776 | ||
| A fluoroquinolone resistance protein from Mycobacterium tuberculosis that mimics DNA. | Q33987554 | ||
| DNA gyrase: an enzyme that introduces superhelical turns into DNA | Q34013173 | ||
| Glutamate racemase is an endogenous DNA gyrase inhibitor | Q34147905 | ||
| Purification and characterization of DNA topoisomerase IV in Escherichia coli | Q34239371 | ||
| Thirty years of Escherichia coli DNA gyrase: from in vivo function to single-molecule mechanism. | Q36775907 | ||
| Thioredoxin can influence gene expression by affecting gyrase activity. | Q37509293 | ||
| The key DNA-binding residues in the C-terminal domain of Mycobacterium tuberculosis DNA gyrase A subunit (GyrA). | Q39117573 | ||
| Tools for characterization of Escherichia coli genes of unknown function | Q39679916 | ||
| GyrI: a counter-defensive strategy against proteinaceous inhibitors of DNA gyrase | Q42724331 | ||
| New avenues in protein function prediction | Q43043672 | ||
| Chromosomally encoded gyrase inhibitor GyrI protects Escherichia coli against DNA-damaging agents | Q44589034 | ||
| Contrasting enzymatic activities of topoisomerase IV and DNA gyrase from Escherichia coli | Q46578341 | ||
| Escherichia coli topoisomerase IV. Purification, characterization, subunit structure, and subunit interactions | Q48092311 | ||
| Overexpression and purification of bacterial DNA gyrase. | Q54522251 | ||
| Immunogold localization of GyrA and GyrB proteins in Escherichia coli. | Q54627894 | ||
| Probing the Binding of Coumarins and Cyclothialidines to DNA Gyrase† | Q57980003 | ||
| The DNA dependence of the ATPase activity of DNA gyrase | Q59695110 | ||
| Identification of DNA gyrase inhibitor (GyrI) in Escherichia coli | Q74088698 | ||
| P433 | issue | 13 | |
| P921 | main subject | Escherichia coli | Q25419 |
| P304 | page(s) | 4310-4316 | |
| P577 | publication date | 2008-06-27 | |
| P1433 | published in | Nucleic Acids Research | Q135122 |
| P1476 | title | YacG from Escherichia coli is a specific endogenous inhibitor of DNA gyrase | |
| P478 | volume | 36 |
| Q35917379 | A biophysical model of supercoiling dependent transcription predicts a structural aspect to gene regulation |
| Q42120870 | A genetic screen in Myxococcus xanthus identifies mutants that uncouple outer membrane exchange from a downstream cellular response |
| Q38399943 | Antibacterial small molecules targeting the conserved TOPRIM domain of DNA gyrase. |
| Q33351258 | Bacterial protein interaction networks: puzzle stones from solved complex structures add to a clearer picture |
| Q40271196 | Curcumin reduces the antimicrobial activity of ciprofloxacin against Salmonella typhimurium and Salmonella typhi |
| Q27684534 | Direct control of type IIA topoisomerase activity by a chromosomally encoded regulatory protein |
| Q34214929 | Exploiting bacterial DNA gyrase as a drug target: current state and perspectives. |
| Q33815635 | Group II intron-anchored gene deletion in Clostridium |
| Q34328014 | Identification and characterization of two functionally unknown genes involved in butanol tolerance of Clostridium acetobutylicum |
| Q42190364 | Identification of ZapD as a cell division factor that promotes the assembly of FtsZ in Escherichia coli |
| Q37694351 | In front of and behind the replication fork: bacterial type IIA topoisomerases. |
| Q53212079 | Inhibition of type IA topoisomerase by a monoclonal antibody through perturbation of DNA cleavage-religation equilibrium. |
| Q39683413 | Molecular basis for the differential quinolone susceptibility of mycobacterial DNA gyrase |
| Q36619820 | Mycobacterium fluoroquinolone resistance protein B, a novel small GTPase, is involved in the regulation of DNA gyrase and drug resistance |
| Q27653930 | Solution structure of the FCS zinc finger domain of the human polycomb group protein L(3)mbt-like 2 |
| Q90170116 | TEX264 coordinates p97- and SPRTN-mediated resolution of topoisomerase 1-DNA adducts |
| Q92148950 | The ATP-dependent chromatin remodelling enzyme Uls1 prevents Topoisomerase II poisoning |
| Q93066662 | The toxin from a ParDE toxin-antitoxin system found in Pseudomonas aeruginosa offers protection to cells challenged with anti-gyrase antibiotics |
| Q49832269 | Topoisomerases as anticancer targets |
Search more.